Bridging Medical Research and Health

The Kolling Research Strategy 2021-2025 will strengthen our ability to achieve ground breaking research, while delivering new opportunities and greater assistance to our teams.

The research strategy will focus on areas of strength, drawing upon the expertise and resources of the University of Sydney and the Northern Sydney Local Health District, and positioning the institute as a centre of translational research excellence.

Researchers will be supported to translate scientific discoveries into positive outcomes for clinical practice and community health.

Research Strategy Brochure

Click here to see our full research strategy or click the button below to download it.

Priority Research Areas

Musculoskeletal – Neuroscience and Pain – Cardiovascular and Renal 

These areas of research investigate some of the biggest health challenges of our time. Collectively, they cost the community billions of dollars a year in health, personal and economic costs.

There is tremendous expertise across these disciplines within the Kolling. Our research teams are well respected, with unique skills and knowledge, strong industry links and a track record of success.

They are well placed to strengthen their international, government and industry collaborations, and increase the impact of their research.

Research Enablers

A key component of the Kolling Institute’s Research Strategy is the provision of four Kolling research enablers. These will provide research teams with new opportunities, modern platforms and infrastructure, increasing competitiveness, career development and core facility support.

Clinical Trials and Translation

Data and Informatics

Research Infrastructure & Support Services

Recruitment and Retention

Events, News and Seminars

Researchers tackle one of the nation’s biggest health challenges

Researchers tackle one of the nation’s biggest health challenges

Researchers from the Kolling Institute will support an important, Australia-wide project to address ..... Read more

Category: Neuroscience and Pain Research, Research Excellence

Researchers partner with industry for innovative study into osteoarthritis

Researchers partner with industry for innovative study into osteoarthritis

Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collabo..... Read more

Category: Musculoskeletal Research, Research Excellence

Expertise at the Kolling recognised

Expertise at the Kolling recognised

Congratulations to Professor David Hunter who’s been announced as a finalist for Research Australia’..... Read more

Category: Awards, Musculoskeletal Research